Patrice Milos

Co-founder, President & CEO at Medley Genomics

Speaker

Dr. Milos co-founded Medley Genomics to deliver novel data analytics for understanding the heterogeneity of complex diseases with an initial focus in oncology. Immediately prior, Patrice was CEO of Claritas Genomics, a pediatric molecular diagnostic company spin-out from Boston Children’s Hospital. Dr. Milos was Boston Site Head for Pfizer’s Centers of Therapeutic Innovation, establishing academic-medical center partnerships to advance novel therapies to treat human disease. She was also SVP/CSO for Helicos BioSciences in Cambridge, MA, and Executive Director for Pfizer Inc, responsible for leading genomics supporting the Pfizer portfolio in precision medicine. Currently, Dr. Milos chairs the Board of Directors for RI Bio, is on the board of RI Venture Mentoring Services and recently served on the European Commission funded ULTRAPLACAD External Advisory Board. Patrice is also Senior Advisor to Binx Health and SeqLL. Patrice earned her MS/PhD at Rensselaer Polytechnic Institute with postdoctoral fellowships at Brown and Harvard.